{{Rsnum
|rsid=9789480
|Chromosome=2
|position=198182902
|Orientation=plus
|GMAF=0.3246
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 5.3 | 44.2 | 50.4
| HCB | 25.5 | 48.9 | 25.5
| JPT | 36.6 | 45.5 | 17.9
| YRI | 0.0 | 6.3 | 93.7
| ASW | 0.0 | 33.9 | 66.1
| CHB | 25.5 | 48.9 | 25.5
| CHD | 25.2 | 47.7 | 27.1
| GIH | 14.9 | 54.5 | 30.7
| LWK | 0.0 | 7.5 | 92.5
| MEX | 17.9 | 50.0 | 32.1
| MKK | 0.0 | 6.5 | 93.5
| TSI | 4.9 | 36.3 | 58.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs9789480
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18776929
|Annotation=This variant is associated with hip bone size in a genome-wide association study (GWAS) consisting of 1,000 homogeneous unrelated Caucasian subjects.
|Drugs=
|Drug Classes=
|Diseases=Fractures, Bone; Hip Fractures; Hip Injuries; Osteoporosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162316703
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9789480
|overall_frequency_n=40
|overall_frequency_d=128
|overall_frequency=0.3125
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=31
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}